Neonatal Hypoglycemia

Neonatal hypoglycemia
 DEFINITION
 PATHOPHYSIOLOGY
 ETIOLOGY
 SCREENING
 MANAGEMENT
INTRODUCTION
 Glucose provides approximately 60% to 70% of fetal energy needs.

 All newborns depend on maternal source for glucose
 The severing of the umbilical cord at birth abruptly interrupts the source of glucose.
 During this normal transition, new born glucose levels fall to a low point in the first one to two hours of life
and then increase to > 45mg/dl,
.
DEFINITION
Various glucose levels are used to describe hypoglycemia, AAP and Paediatric endocrine society guidelines
are most widely used to provide margin of safety.
Based on Symptomatic – newborn <48 hours of life-if glucose is <50mg/dl of plasma glucose.
new born is age >48 hrs of life- hypoglycemia <60mg/dl.
Asymptomatic-At risk
<4hrs of life-glucose <25mg/dl
4 and 24hrs-glucose<35mg/dl
24-48hrs-glucose <50 mg/dl
>48hrs-Glucose<60mg/dl
AT RISK
 Birth weight <2 kg or >4 kg

 Large for gestational age (LGA)
 Small for gestational age (SGA)
 Intra uterine growth restriction (IUGR)
 Neonates of insulin dependent mother (1:1000 pregnant women)
 Mothers with gestational diabetes (-2% of pregnant women)
 Preterm or late preterm neonates.
 Suspected of sepsis or chorioamnionitis
 Significant hypoxia
 Perinatal distress
 Hypothermia
 Isolated hepatomegaly
 Microcephaly
 Multiple congenital anomalies
 Suspected in born error of metabolism
 Maternal history of terbutaline, betablockers, or oral hypoglycemic medications
PATHOPHYSIOLOGY
 Hormones which regulate glucose levels

 -Insulin
 -Glucagon
 When glucose levels fall
 •Glycogen is secreted to increase glucose levels through glycogenolysis
 •Glycogenolysis releases glucose back into the blood
ETIOLOGY
 Inappropriate changes in hormone secretion

 Inadequate substrate reserve-Hepatic glycogen
 Inadequate muscle stores
 Source of amino acids for gluconeogenesis
 Inadequate lipid stores
 Release of fatty acids
ETIOLOGY
 Hyperinsulinemic-Increased insulin-more glucose utilization

a)IDM
b)CONGENITAL- GENETIC-SUR1,Kir6.2
c) SECONDARY TO OTHER CONDITION LIKE –birth asphyxia,Beckwith wiedemann
syndrome,erythroblastosis,maternal tocolytic therapy-terbulatin,malposition of umbilical artery catheter,at level
T11-T12-stimulate insulin release,abrubt cessation of high glucose infusion,after exchange transfusion,insulin
producing tumors
 Decreased production/stores
Prematurity,IUGR/SGA,poor intake,delayed feeding
 Increased utilization-Perinatal stress,after exchange transfusion,
 Defect in CHO metabolism
 Endocrine deficiency
 Defects in aminoacid metabolism
 Polycythemia-due to increased red cells-inturn utilize more glucose
 Maternal/infant therapy-B blockers-labetalol,
SIGNS AND SYMPTOMS
Fall into two categories

 -Neurogenic symptoms
•Affect activity along the sympathetic nervous system
•Are both adrenergic and cholinergic
 Adrenergic symptoms ,Anxiety, tremulousness,Tachycardia Palpitations
 -Cholinergic symptoms•Diaphoresis,Pallor,Hunger, nausea, and vomiting
 -Neuroglycopenic symptoms
•Due to brain dysfunction from a deficient glucose supply
 Hypotonia
 Lethargy, apathy
 Tachypnea, apnea
 Poor feeding
 Jitteriness, seizures
 Congestive heart failure
 Cyanosis
 Apnea
 Hypothermia, temperature instability
RECOMMENDATIONS
1) Symptomatic newborn with GRBS < 40mg/dl; patient with IV infusion

2) Symptomatic
a) In 1st 4 hours
i. If 1st hours <25mg/dl – give feeds , check again
if 35-45 then give feeds
if <25 then start infusion
ii. If suspending check in between 35-40 give feeds.
b) In next 24 hours
i. If glucose in <35mg /dl – initiate feed
ii. After feed <35 start infusion
iii. If.35-40mg/dl – start and continue feeds.
iv. target to maintain >45mg/dl
c) According to PES -48-72hr,
blood glucose – (glucometer) 50 mg/dl
glucose strips ± 10 -15 mg/dl varies ; and generally it is 15% lower than plasma levels
SCREENING
 Whom all to screen

 At high risk
 Inability to maintain preprandial plasma glucose levels
>50mg/dl in <48hours or glucose levels
>60 mg/dl in >48hrs of life
 Persistent hypoglycemia –requiring GIR of 8-10 mg/kg/min
 Evaluate-for Hyperinsulinemia-to send plasma glucose,cortisols,insulin,B hydroxybuterate and FFA,C
peptide
 If insulin is normal-then consider defect in metabolism of harmone
• T3,T4,TSH,Growth harmone
• ACTH
• Glucagon
• Plasma aminoacid
• Urine-reducing substtances, sugars,amino acids/Organic acids.
o Genitic analysis-SUR1,KiR6.2
Management
 Feeding
 GIR should be monitored(if requiring >12,then give via central line)
 Hydrocortisone-If GIR>12-15mgkg/min(10mg/kg/day Q8hry)-reduces peripheral glucose uptake,and inc
gluconeogenesis.
 Diazoxide 8-15mg/kg/day in Q12 hry/8th hrly(for hyper insulinemic state),
 Octreotide-5-20mg/kg/day-Sc/Iv Q8hry-Q6hrly.Long acting somatostatin analogue-inhibit insulin secretion.
 Glucagon-0.2mg/kg iv/sc/im
 Surgical correction.
 GIR calculation= DxR
6 x weight
 Ex -10 % dextrose,At 12 ml/hr and weight of baby is 3 kg= GIR=6.6mg/kg/min

LONG TERM OUTCOME
 Major long-term sequelae include

• -Neurologic damage
• •Mental retardation
• • Recurrent seizure activity, epilepsy
• • Cerebral palsy
• • Developmental delay
INBORN ERROR OF METABOLISM
ASSOCIATED WITH HYPOGLYCEMIA
TAKE AWAY MESSAGE
 To differentiate between symptomatic and asymptomatic hypoglycemia.

 At risk groups
 Early management
 GIR calculation,
 To know the outcomes.

Neonatal Hypoglycemia

Uploaded by

Copyright:

Available Formats

Neonatal Hypoglycemia

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Neonatal Hypoglycemia

Uploaded by

Copyright:

Available Formats

Neonatal hypoglycemia

 Glucose provides approximately 60% to 70% of fetal energy needs.

 Birth weight <2 kg or >4 kg

 Hormones which regulate glucose levels

 Inappropriate changes in hormone secretion

 Hyperinsulinemic-Increased insulin-more glucose utilization

Fall into two categories

1) Symptomatic newborn with GRBS < 40mg/dl; patient with IV infusion

 Whom all to screen

 Ex -10 % dextrose,At 12 ml/hr and weight of baby is 3 kg= GIR=6.6mg/kg/min

 Major long-term sequelae include

 To differentiate between symptomatic and asymptomatic hypoglycemia.

You might also like